Form F-3 - Registration statement by foreign private issuers:
SEC Accession No. 0001144204-08-047986
Filing Date
2008-08-15
Accepted
2008-08-15 17:09:56
Documents
4

Document Format Files

Seq Description Document Type Size
1 v123228_f3.htm F-3 297264
2 GRAPHIC v1232281.jpg GRAPHIC 4158
3 v123228_ex23-1.htm EX-23.1 6998
4 v123228_ex23-2.htm EX-23.2 8514
  Complete submission text file 0001144204-08-047986.txt   320000
Mailing Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989
Business Address 711 EXECUTIVE BOULEVARD SUITE Q VALLEY COTTAGE NY 10989 972-8-930-4440
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: F-3 | Act: 33 | File No.: 333-153055 | Film No.: 081023540
SIC: 2834 Pharmaceutical Preparations